The following represents disclosure information provided by authors of this abstract. The Breast Cancer Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
BRCA-1 promotor methylation as predictor of benefit from adjuvant CMF in triple-negative breast cancer not responsive to taxane-based neoadjuvant chemotherapy.
Rupert Bartsch
No relevant relationships to disclose
Mathilde Födermayr
No relevant relationships to disclose
Miriam Sebesta
No relevant relationships to disclose
Margaretha Rudas
No relevant relationships to disclose
Anna Sophie Berghoff
No relevant relationships to disclose
Regina Promberger
No relevant relationships to disclose
Matthias Preusser
No relevant relationships to disclose
Peter Christian Dubsky
No relevant relationships to disclose
Florian Fitzal
No relevant relationships to disclose
Michael Gnant
No relevant relationships to disclose
Ansgar Weltermann
No relevant relationships to disclose
Christoph Zielinski
No relevant relationships to disclose
Guenther G. Steger
No relevant relationships to disclose
Otto Zach
No relevant relationships to disclose